ABRF Research Groups to Spearhead FDA's Sequence Quality Control Project

Four ABRF research groups will perform the analysis for the Sequence Quality Control project, a continuation of the FDA-led Microarray Quality Control project that aims to assess the technical performance of next-generation sequencing platforms.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.